The UK’s world-leading life sciences sector will receive a £279 million boost with an intent expressed by Lilly to invest in the UK as part of a collaborative partnership with UK government, announced at the International Investment Summit. The first ‘Lilly Gateway Labs’ innovation accelerator in Europe will support early-stage life sciences businesses to develop transformative medicines by providing lab space, mentorship and potential financial backing to rocket future growth in the sector.  Source: Fierce Biotech 14/10/2024